Logo image of CBLU.CA

CLEAR BLUE TECHNOLOGIES INTE (CBLU.CA) Stock Fundamental Analysis

Canada - TSX-V:CBLU - CA18453C4048 - Common Stock

0.055 CAD
+0 (+10%)
Last: 10/16/2025, 7:00:00 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to CBLU. CBLU was compared to 34 industry peers in the Independent Power and Renewable Electricity Producers industry. CBLU has a bad profitability rating. Also its financial health evaluation is rather negative. CBLU is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

CBLU had negative earnings in the past year.
CBLU had a negative operating cash flow in the past year.
In the past 5 years CBLU always reported negative net income.
In the past 5 years CBLU reported 4 times negative operating cash flow.
CBLU.CA Yearly Net Income VS EBIT VS OCF VS FCFCBLU.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

CBLU has a Return On Assets of -171.11%. This is amonst the worse of the industry: CBLU underperforms 82.35% of its industry peers.
Industry RankSector Rank
ROA -171.11%
ROE N/A
ROIC N/A
ROA(3y)-91.59%
ROA(5y)-79.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CBLU.CA Yearly ROA, ROE, ROICCBLU.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K

1.3 Margins

CBLU has a Gross Margin of 58.05%. This is comparable to the rest of the industry: CBLU outperforms 58.82% of its industry peers.
CBLU's Gross Margin has improved in the last couple of years.
CBLU does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 58.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.92%
GM growth 5Y34.25%
CBLU.CA Yearly Profit, Operating, Gross MarginsCBLU.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

CBLU does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CBLU has more shares outstanding
Compared to 5 years ago, CBLU has more shares outstanding
CBLU has a worse debt/assets ratio than last year.
CBLU.CA Yearly Shares OutstandingCBLU.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CBLU.CA Yearly Total Debt VS Total AssetsCBLU.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

CBLU has an Altman-Z score of -10.08. This is a bad value and indicates that CBLU is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -10.08, CBLU perfoms like the industry average, outperforming 41.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -10.08
ROIC/WACCN/A
WACC4.73%
CBLU.CA Yearly LT Debt VS Equity VS FCFCBLU.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 1.45 indicates that CBLU should not have too much problems paying its short term obligations.
CBLU's Current ratio of 1.45 is amongst the best of the industry. CBLU outperforms 82.35% of its industry peers.
CBLU has a Quick Ratio of 1.45. This is a bad value and indicates that CBLU is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.58, CBLU is not doing good in the industry: 64.71% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.45
Quick Ratio 0.58
CBLU.CA Yearly Current Assets VS Current LiabilitesCBLU.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M

More info and screens

0

3. Growth

3.1 Past

CBLU shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -145.76%.
Looking at the last year, CBLU shows a very negative growth in Revenue. The Revenue has decreased by -49.77% in the last year.
Measured over the past years, CBLU shows a very negative growth in Revenue. The Revenue has been decreasing by -19.07% on average per year.
EPS 1Y (TTM)-145.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.17%
Revenue 1Y (TTM)-49.77%
Revenue growth 3Y-30.31%
Revenue growth 5Y-19.07%
Sales Q2Q%11.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CBLU.CA Yearly Revenue VS EstimatesCBLU.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CBLU reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CBLU.CA Price Earnings VS Forward Price EarningsCBLU.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CBLU.CA Per share dataCBLU.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CBLU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEAR BLUE TECHNOLOGIES INTE

TSX-V:CBLU (10/16/2025, 7:00:00 PM)

0.055

+0 (+10%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)08-25 2025-08-25
Earnings (Next)11-26 2025-11-26
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners8.82%
Ins Owner ChangeN/A
Market Cap4.32M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.39
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.42
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)0
OCFYN/A
SpS0.04
BVpS-0.06
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -171.11%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 58.05%
FCFM N/A
ROA(3y)-91.59%
ROA(5y)-79.28%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y20.92%
GM growth 5Y34.25%
F-Score4
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 361.77%
Cap/Sales 54.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.45
Quick Ratio 0.58
Altman-Z -10.08
F-Score4
WACC4.73%
ROIC/WACCN/A
Cap/Depr(3y)447.97%
Cap/Depr(5y)674.75%
Cap/Sales(3y)81.26%
Cap/Sales(5y)56.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-145.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.17%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-49.77%
Revenue growth 3Y-30.31%
Revenue growth 5Y-19.07%
Sales Q2Q%11.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y12.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y64.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y88.66%
OCF growth 3YN/A
OCF growth 5YN/A